The Unwinding of Circular Deoxyribonucleic Acid by Phenanthridinium Drugs: Structure-Activity Relations for the Intercalation Reaction

The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how substituents on the phenanthridine chromophore affect its capacity to intercalate between the DNA base pairs. Variations in the quaternising group at po...

Full description

Saved in:
Bibliographic Details
Published inMolecular pharmacology Vol. 10; no. 3; pp. 544 - 561
Main Authors WAKELIN, L.P.G., WARING, M.J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.05.1974
American Society for Pharmacology and Experimental Therapeutics
Subjects
Online AccessGet full text
ISSN0026-895X
1521-0111
DOI10.1016/S0026-895X(25)13944-8

Cover

Abstract The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how substituents on the phenanthridine chromophore affect its capacity to intercalate between the DNA base pairs. Variations in the quaternising group at position 5 have little or no effect. The presence of a phenyl substituent at position 6 strongly influences external attachment to the DNA helix and affects the unwinding angle. Introduction of a p-carboxyl group on the phenyl ring leads to weaker binding. Free primary amino groups at positions 3 and 8 are not mandatory for the intercalation reaction, but their presence adds stability to the complex (approximately 1.7 kcal/mole). Removal of the 3-amino group has little effect other than a small reduction in the unwinding angle, whereas acetylation of the 8-amino gruop results in weaker binding as well as a lowered unwinding angle. Replacement of both 3- and 8-amino groups by carbethoxyamino substituents leads to markedly weaker binding and an apparent unwinding angle of only 5.1° ± 0.6°, the lowest value observed with any phenanthridine, together with other consequences which suggest a radical alteration in the mechanism of binding to DNA. Introduction of bromine atoms in place of amino groups at positions 3 and 8 yields a heavy-atom derivative which still unwinds the DNA helix by the same angle as ethidium at low ionic strength. Structure-activity correlations for the intercalation reaction deduced from these studies are in agreement with earlier findings relating to antimicrobial activity. ACKNOWLEDGMENTS We thank and Mr. N. F. Totty for skilled technical assistance, and many colleagues for helpful advice and criticism. We are especially grateful to Drs. R. Slack, S. S. Berg, and G. Woolfe for generous supplies of the drugs, together with precise analytical data on their chemical constitution.
AbstractList The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how substituents on the phenanthridine chromophore affect its capacity to intercalate between the DNA base pairs. Variations in the quaternising group at position 5 have little or no effect. The presence of a phenyl substituent at position 6 strongly influences external attachment to the DNA helix and affects the unwinding angle. Introduction of a p-carboxyl group on the phenyl ring leads to weaker binding. Free primary amino groups at positions 3 and 8 are not mandatory for the intercalation reaction, but their presence adds stability to the complex (approximately 1.7 kcal/mole). Removal of the 3-amino group has little effect other than a small reduction in the unwinding angle, whereas acetylation of the 8-amino gruop results in weaker binding as well as a lowered unwinding angle. Replacement of both 3- and 8-amino groups by carbethoxyamino substituents leads to markedly weaker binding and an apparent unwinding angle of only 5.1° ± 0.6°, the lowest value observed with any phenanthridine, together with other consequences which suggest a radical alteration in the mechanism of binding to DNA. Introduction of bromine atoms in place of amino groups at positions 3 and 8 yields a heavy-atom derivative which still unwinds the DNA helix by the same angle as ethidium at low ionic strength. Structure-activity correlations for the intercalation reaction deduced from these studies are in agreement with earlier findings relating to antimicrobial activity. ACKNOWLEDGMENTS We thank and Mr. N. F. Totty for skilled technical assistance, and many colleagues for helpful advice and criticism. We are especially grateful to Drs. R. Slack, S. S. Berg, and G. Woolfe for generous supplies of the drugs, together with precise analytical data on their chemical constitution.
The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how substituents on the phenanthridine chromophore affect its capacity to intercalate between the DNA base pairs. Variations in the quaternising group at position 5 have little or no effect. The presence of a phenyl substituent at position 6 strongly influences external attachment to the DNA helix and affects the unwinding angle. Introduction of a p -carboxyl group on the phenyl ring leads to weaker binding. Free primary amino groups at positions 3 and 8 are not mandatory for the intercalation reaction, but their presence adds stability to the complex (approximately 1.7 kcal/mole). Removal of the 3-amino group has little effect other than a small reduction in the unwinding angle, whereas acetylation of the 8-amino gruop results in weaker binding as well as a lowered unwinding angle. Replacement of both 3- and 8-amino groups by carbethoxyamino substituents leads to markedly weaker binding and an apparent unwinding angle of only 5.1° ± 0.6°, the lowest value observed with any phenanthridine, together with other consequences which suggest a radical alteration in the mechanism of binding to DNA. Introduction of bromine atoms in place of amino groups at positions 3 and 8 yields a heavy-atom derivative which still unwinds the DNA helix by the same angle as ethidium at low ionic strength. Structure-activity correlations for the intercalation reaction deduced from these studies are in agreement with earlier findings relating to antimicrobial activity.
Author WAKELIN, L.P.G.
WARING, M.J.
Author_xml – sequence: 1
  givenname: L.P.G.
  surname: WAKELIN
  fullname: WAKELIN, L.P.G.
– sequence: 2
  givenname: M.J.
  surname: WARING
  fullname: WARING, M.J.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/4859556$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFu1DAQhi1UVLaFR6jkCwgOKXZiex04oNUWSqVKINpK3CzHmWyMsvZiOy37Ajw33s3CgUtPtub_vxnN_CfoyHkHCJ1Rck4JFW9vCClFIWv-_XXJ39CqZqyQT9CM8pIWhFJ6hGb_LM_QSYw_CKGMS3KMjpnkNedihn7f9oDv3IN1rXUr7Du8tMGMgw74AvyvbbCNd6MZwBq8MLbFzRZ_7cFpl_pgM2PHNb4I4yq-wzcpjCaNAYqFSfbepi3-BoNO1ruIOx9wyrOuXIJg9FTOuja7z3P0tNNDhBeH9xTdffp4u_xcXH-5vFourgtTEZ6KuezKRlRA2Jw1nJOy1mUNuiJMCMGA1wRk11LZ1G3XgZZsXlWM5KKci5ZXVXWKXk19N8H_HCEmtbbRwDBoB36MSpa8rAUX2Xh2MI7NGlq1CXatw1YdDpf195Nugo8xQKeMTfudUtB2UJSoXUpqn5LaRaBKrvYpKZlp_h_9t_9j3MuJ6-2qf7AB1KbXYa2NH_xqD1eKM5Z9HyYf5FveWwgqGgvOQJsZk1Tr7SOT_gCUE7kG
CitedBy_id crossref_primary_10_1002_chem_200902823
crossref_primary_10_1016_0360_3016_92_90871_E
crossref_primary_10_1002_qua_560160716
crossref_primary_10_1111_j_2042_7158_1976_tb04122_x
ContentType Journal Article
Copyright 1974 American Society for Pharmacology and Experimental Therapeutics
Copyright_xml – notice: 1974 American Society for Pharmacology and Experimental Therapeutics
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/S0026-895X(25)13944-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
Chemistry
EISSN 1521-0111
EndPage 561
ExternalDocumentID 4859556
10_1016_S0026_895X_25_13944_8
10_3_544
S0026895X25139448
Genre Journal Article
GroupedDBID ---
-~X
.55
.GJ
0R~
123
18M
2WC
34G
39C
4.4
53G
5RE
5VS
AAJMC
AALRI
AAXUO
ABCQX
ABJNI
ABSQV
ACGFO
ACGFS
ADBBV
ADCOW
AENEX
AERNN
AFFNX
AFHIN
AFOSN
ALMA_UNASSIGNED_HOLDINGS
AYCSE
BAWUL
BTFSW
CS3
DIK
E3Z
EBS
EJD
F5P
F9R
FDB
GX1
H13
HH5
HZ~
IH2
INIJC
K-O
KQ8
L7B
LSO
M41
MVM
N9A
O9-
OK1
P2P
R.V
R0Z
RHF
RHI
ROL
RPT
TR2
UQL
W8F
WOQ
X7M
XOL
YBU
YHG
ZGI
ZXP
-
08R
0R
55
AALRV
AAPBV
ABFLS
ABSGY
ABZEH
ADBIT
DL
FH7
GJ
HZ
X
ZA5
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c305t-78f2b63e0474b55029a29ea3046664e590e8fd18b9dffea84733400e8876d5333
ISSN 0026-895X
IngestDate Fri Sep 05 11:21:51 EDT 2025
Tue Aug 05 11:39:52 EDT 2025
Thu Apr 24 23:02:10 EDT 2025
Tue Jul 01 05:36:05 EDT 2025
Tue Jan 05 21:16:52 EST 2021
Sat Feb 08 15:52:06 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c305t-78f2b63e0474b55029a29ea3046664e590e8fd18b9dffea84733400e8876d5333
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 4859556
PQID 82529656
PQPubID 23479
PageCount 18
ParticipantIDs proquest_miscellaneous_82529656
pubmed_primary_4859556
crossref_citationtrail_10_1016_S0026_895X_25_13944_8
crossref_primary_10_1016_S0026_895X_25_13944_8
highwire_pharmacology_10_3_544
elsevier_sciencedirect_doi_10_1016_S0026_895X_25_13944_8
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1974-May
PublicationDateYYYYMMDD 1974-05-01
PublicationDate_xml – month: 05
  year: 1974
  text: 1974-May
PublicationDecade 1970
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Molecular pharmacology
PublicationTitleAlternate Mol Pharmacol
PublicationYear 1974
Publisher Elsevier Inc
American Society for Pharmacology and Experimental Therapeutics
Publisher_xml – name: Elsevier Inc
– name: American Society for Pharmacology and Experimental Therapeutics
SSID ssj0014580
Score 1.2900113
Snippet The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how...
The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how...
SourceID proquest
pubmed
crossref
highwire
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 544
SubjectTerms Amines
Animals
Bacteriophages
Bromine
Buffers
Cattle
Chemical Phenomena
Chemistry
Dialysis
Dimethyl Sulfoxide
DNA, Circular
Ethidium - pharmacology
Phenanthridines - pharmacology
Spectrophotometry, Ultraviolet
Structure-Activity Relationship
Thymus Gland
Ultracentrifugation
Title The Unwinding of Circular Deoxyribonucleic Acid by Phenanthridinium Drugs: Structure-Activity Relations for the Intercalation Reaction
URI https://dx.doi.org/10.1016/S0026-895X(25)13944-8
http://molpharm.aspetjournals.org/content/10/3/544.abstract
https://www.ncbi.nlm.nih.gov/pubmed/4859556
https://www.proquest.com/docview/82529656
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVgvPCCxsdE-Rh-YBOoS0gcO3F4q9hgbCsqWyv1zYpTl0Ua6dS1gvID-N1c20ncbkyDvURRYjuRzrF9r33PNUKvOU31wdWxlwOZPMoD6nGd9DMD0z7kIx4msdYOd7_E-wN6MGRDt11g1CUz6ee__qoruQ2q8Axw1SrZ_0C2aRQewD3gC1dAGK7_jPGg_FFYZYoOrCimNq50V01-LqaFnJQ6X3GRtzt5YUzN3qnSoS-n0wLqFPPv7d3p_JsJizsxmWTnU-V18upICRcpVwcjmgVEgNXS5lhZWcSyhdutz9ttn7us2G7dvnO4d_TZhBYc-T3_k-9eHFfyqa5_4Lu1iBA8ERf5ZxfIapHMSgyndvOAAGy4MugGS-SKlkZQZtNBVpMxs5nar4zzdsnhpGl6S0twt4jOcUqpx93k1oQcmrK6KBh0uhC_i-6RJDFb-4df3c4TZdzKlqqWnerrnfvcG8LeVp-6zp5p0k1f77oYE6a_jh5UvgfuWCI9RHdU-Qht9yxMix3cd1q8ix28jXtLAD5Gv-E1btiGJ2Ncsw1fZhvWbMNygS-zDRu2vcdXuYYbrmHgGgau4RWu4ZprT9Dg417_w75XneJhuv_MS_iYyDhSAU2oBH-YpBlJVaZ35OOYKpYGio9HIZfpaDxWGVhLUQQTi4LZLx6BMxJtoLVyUqqnCDNFooRENFZaEZ3LNMhCxuVIZiqF6qSFaI2FyKsU9_qklTPhYhkBQqEhFIQJA6HgLeQ31c5tjpebKvAaaFEZqtYAFcDPm6pu1sQQy91Q14oEkL-FXtV0ETDS6-27rFST-YUAhpMU3K8W2rAsan6W6iSFLH52-996ju67_vwCrQEL1Euwtmdy03SPPxddz54
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Unwinding+of+Circular+Deoxyribonucleic+Acid+by+Phenanthridinium+Drugs%3A+Structure-Activity+Relations+for+the+Intercalation+Reaction&rft.jtitle=Molecular+pharmacology&rft.au=WAKELIN%2C+L.P.G.&rft.au=WARING%2C+M.J.&rft.date=1974-05-01&rft.pub=Elsevier+Inc&rft.issn=0026-895X&rft.volume=10&rft.issue=3&rft.spage=544&rft.epage=561&rft_id=info:doi/10.1016%2FS0026-895X%2825%2913944-8&rft.externalDocID=S0026895X25139448
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0026-895X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0026-895X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0026-895X&client=summon